Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Personalized Management of Pheochromocytoma and Paraganglioma.

Endocrine reviews - 9 Mar 2022

Nölting Svenja, Bechmann Nicole, Taieb David, Beuschlein Felix, Fassnacht Martin, Kroiss Matthias, Eisenhofer Graeme, Grossman Ashley, Pacak Karel

Abstract excerpt

Pheochromocytomas/paragangliomas are characterized by a unique molecular landscape that allows their assignment to clusters based on underlying genetic alterations. With around 30% to 35% of Caucasian patients (a lower percentage in the Chinese population) showing germline mutations in susceptibility genes, pheochromocytomas/paragangliomas have the highest rate of heritability among all tumors. A further 35% to...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adrenal and Paraganglionic Tumors
Share to Adrenal Gland Neoplasms

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cancer, Hypoxia, and Metabolism

Share to Germ-Line Mutation

Share to Hormonal Regulation and Hypertension

Share to Mutation

Share to Paraganglioma

Share to Pheochromocytoma

Source

Open in PubMed Open full text

Identifiers

PMID: 34147030
DOI: 10.1210/endrev/bnab019
PMCID: PMC8905338

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Personalized Management of Pheochromocytoma and Paraganglioma.PMID 34147030Read ↗

The Management of Phaeochromocytomas and Paragangliomas in the Era of Precision Medicine: Where Are We Now? Evidence-Based Systemic Treatment Options and Future Cluster Oriented PerspectivesSemantic proximity Read ↗

Current Management of Pheochromocytoma/Paraganglioma: A Guide for the Practicing Clinician in the Era of Precision MedicineSemantic proximity Read ↗

New Perspectives on Pheochromocytoma and Paraganglioma: Toward a Molecular Classification.Semantic proximity Read ↗

Pheochromocytoma and paraganglioma pathogenesis: learning from genetic heterogeneity.Semantic proximity Read ↗

Genetics of Pheochromocytomas and Paragangliomas Determine the Therapeutical Approach.Semantic proximity Read ↗

Comprehensive Molecular Characterization of Pheochromocytoma and Paraganglioma.Semantic proximity Read ↗

The Molecular Classification of Pheochromocytomas and Paragangliomas: Discovering the Genomic and Immune Landscape of Metastatic DiseaseSemantic proximity Read ↗

Pheochromocytomas and Paragangliomas: From Genetic Diversity to Targeted TherapiesSemantic proximity Read ↗

Diagnosis for Pheochromocytoma and Paraganglioma: A Joint Position Statement of the Korean Pheochromocytoma and Paraganglioma Task ForceSemantic proximity Read ↗

Multidisciplinary practice guidelines for the diagnosis, genetic counseling and treatment of pheochromocytomas and paragangliomas.Semantic proximity Read ↗

Pheochromocytoma and Paraganglioma: Genetics, Diagnosis, and Treatment.Semantic proximity Read ↗

Genomic Landscape of Pheochromocytoma and Paraganglioma.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.